Live Breaking News & Updates on Finch Therapeutics Group Stock Performance

Stay updated with breaking news from Finch therapeutics group stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Finch Therapeutics Group (NASDAQ:FNCH) Shares Set to Reverse Split on Monday, June 12th

Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Rating) shares are scheduled to reverse split before the market opens on Monday, June 12th. The 1-30 reverse split was announced on Monday, June 12th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, June 12th. Finch Therapeutics Group Stock Performance […] ....

United States , Millennium Management , Finch Therapeutics Group Inc , Goldman Sachs Group Inc , Baupost Group , News Ratings For Finch Therapeutics Group Daily , Renaissance Technologies , Finch Therapeutics Group Stock Performance , Finch Therapeutics Group , Get Rating , Therapeutics Group , Goldman Sachs Group , Finch Therapeutics Group Daily , Nasdaq Fnch , Stock Split ,

HC Wainwright Trims Finch Therapeutics Group (NASDAQ:FNCH) Target Price to $7.00

Finch Therapeutics Group (NASDAQ:FNCH – Get Rating) had its price objective trimmed by HC Wainwright from $17.00 to $7.00 in a report released on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Finch Therapeutics Group’s Q1 2023 earnings at ($0.09) EPS, Q2 2023 earnings at ($0.03) EPS, Q3 2023 earnings at ($0.03) […] ....

United States , Finch Therapeutics Group Stock Performance , Renaissance Technologies , Virtu Financial , Millennium Management , News Ratings For Finch Therapeutics Group Daily , Finch Therapeutics Group Inc , Finch Therapeutics Group , Goldman Sachs Group Inc , Get Rating , Sachs Group , Therapeutics Group , Finch Therapeutics Group Daily , Nasdaq Fnch , Lower Price Target , Hc Wainwright ,